These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 26880003)

  • 1. Long-term radiographic follow-up of bisphosphonate-associated atypical femur fractures.
    Favinger JL; Hippe D; Ha AS
    Skeletal Radiol; 2016 May; 45(5):627-33. PubMed ID: 26880003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The advantages of tomosynthesis for evaluating bisphosphonate-related atypical femur fractures compared to radiography.
    Petraszko A; Siegal D; Flynn M; Rao SD; Peterson E; van Holsbeeck M
    Skeletal Radiol; 2016 May; 45(5):615-23. PubMed ID: 26861160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural history of incomplete atypical femoral fractures in patients after a prolonged and variable course of bisphosphonate therapy-a long-term radiological follow-up.
    Png MA; Mohan PC; Koh JSB; Howe CY; Howe TS
    Osteoporos Int; 2019 Dec; 30(12):2417-2428. PubMed ID: 31435684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is surgery necessary for femoral insufficiency fractures after long-term bisphosphonate therapy?
    Ha YC; Cho MR; Park KH; Kim SY; Koo KH
    Clin Orthop Relat Res; 2010 Dec; 468(12):3393-8. PubMed ID: 20865463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonoperative versus prophylactic treatment of bisphosphonate-associated femoral stress fractures.
    Banffy MB; Vrahas MS; Ready JE; Abraham JA
    Clin Orthop Relat Res; 2011 Jul; 469(7):2028-34. PubMed ID: 21350886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lateral Cortical Thickening and Bone Heterogeneity of the Subtrochanteric Femur Measured With Quantitative CT as Indicators for Early Detection of Atypical Femoral Fractures in Long-Term Bisphosphonate Users.
    Lee SH; Lee YH; Suh JS
    AJR Am J Roentgenol; 2017 Oct; 209(4):867-873. PubMed ID: 28796551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Undisturbed local bone formation capacity in patients with atypical femoral fractures: a case series.
    Bögl HP; Aspenberg P; Schilcher J
    Osteoporos Int; 2017 Aug; 28(8):2439-2444. PubMed ID: 28474166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors Associated with Increased Healing Time in Complete Femoral Fractures After Long-Term Bisphosphonate Therapy.
    Lim HS; Kim CK; Park YS; Moon YW; Lim SJ; Kim SM
    J Bone Joint Surg Am; 2016 Dec; 98(23):1978-1987. PubMed ID: 27926679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical outcome of atypical subtrochanteric and femoral fracture related to bisphosphonates use in osteoporotic patients with or without teriparatide treatment.
    Yeh WL; Su CY; Chang CW; Chen CH; Fu TS; Chen LH; Lin TY
    BMC Musculoskelet Disord; 2017 Dec; 18(1):527. PubMed ID: 29237448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Femoral insufficiency fractures associated with prolonged bisphosphonate therapy.
    Isaacs JD; Shidiak L; Harris IA; Szomor ZL
    Clin Orthop Relat Res; 2010 Dec; 468(12):3384-92. PubMed ID: 20809164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Healing delayed but generally reliable after bisphosphonate-associated complete femur fractures treated with IM nails.
    Egol KA; Park JH; Rosenberg ZS; Peck V; Tejwani NC
    Clin Orthop Relat Res; 2014 Sep; 472(9):2728-34. PubMed ID: 23604648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of femoral fracture nonunion after long-term bisphosphonate use.
    Grady MK; Watson JT; Cannada LK
    Orthopedics; 2012 Jun; 35(6):e991-5. PubMed ID: 22691683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bisphosphonate-associated fractures of the femur: pathophysiology and treatment.
    Einhorn TA; Bogdan Y; Tornetta P
    J Orthop Trauma; 2014 Jul; 28(7):433-8. PubMed ID: 24121986
    [No Abstract]   [Full Text] [Related]  

  • 14. Frequency of incomplete atypical femoral fractures in asymptomatic patients on long-term bisphosphonate therapy.
    La Rocca Vieira R; Rosenberg ZS; Allison MB; Im SA; Babb J; Peck V
    AJR Am J Roentgenol; 2012 May; 198(5):1144-51. PubMed ID: 22528906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Femoral cortical stress lesions in long-term bisphosphonate therapy: a herald of impending fracture?
    Koh JS; Goh SK; Png MA; Kwek EB; Howe TS
    J Orthop Trauma; 2010 Feb; 24(2):75-81. PubMed ID: 20101130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Femoral stress fractures associated with long-term bisphosphonate treatment.
    Ward WG; Carter CJ; Wilson SC; Emory CL
    Clin Orthop Relat Res; 2012 Mar; 470(3):759-65. PubMed ID: 22125247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progression of atypical femur stress fracture after discontinuation of bisphosphonate therapy.
    Gu KD; Ettinger B; Grimsrud CD; Lo JC
    Osteoporos Int; 2021 Oct; 32(10):2119-2123. PubMed ID: 33914104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensitivity and specificity of radiographic characteristics in atypical femoral fractures.
    Adams AL; Xue F; Chantra JQ; Dell RM; Ott SM; Silverman S; Giaconi JC; Critchlow C
    Osteoporos Int; 2017 Jan; 28(1):413-417. PubMed ID: 27766369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bisphosphonate-associated atypical fracture of the femur: Spontaneous healing with drug holiday and re-appearance after resumed drug therapy with bilateral simultaneous displaced fractures--a case report.
    Puah KL; Tan MH
    Acta Orthop; 2011 Jun; 82(3):380-2. PubMed ID: 21561306
    [No Abstract]   [Full Text] [Related]  

  • 20. Bisphosphonate-related femoral periosteal stress reactions: scoring system based on radiographic and MRI findings.
    Png MA; Koh JS; Goh SK; Fook-Chong S; Howe TS
    AJR Am J Roentgenol; 2012 Apr; 198(4):869-77. PubMed ID: 22451554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.